Literature DB >> 7812772

Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate.

P J Shaw1, R M Chinnery, P G Ince.   

Abstract

The distribution and density of non-NMDA receptors in spinal cord and motor cortex was compared in 10 cases of motor neuron disease (MND) and 8 neurologically normal controls by quantitative autoradiography using [3H]CNQX and [3H]kainate. In the motor cortex of MND cases, an increased density of [3H]kainate binding sites was observed which was most marked in the deep layers. No significant differences were observed in [3H]CNQX binding in the motor cortex between MND and control cases. In the spinal cord significantly increased densities of both [3H]CNQX and [3]kainate binding sites were found in the substantia gelatinosa and the intermediate grey matter in the MND group. The changes in [3H]kainate binding were observed only in the amyotrophic lateral sclerosis (ALS) subgroup of MND, while the changes in [3H]CNQX binding in the spinal cord were more marked in ALS compared to progressive muscular atrophy (PMA) cases. These findings provide evidence in support of a disturbance of glutamatergic neurotransmission in MND and suggest that there may be an increased excitatory drive to motor neurons via non-NMDA receptors. It is unclear at present whether the changes observed represent a compensatory response to loss of motor neurons in MND or a pathophysiological phenomenon contributing to motor neuron degeneration. Modulation of non-NMDA receptor activity may represent a possible target for therapeutic intervention in this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812772     DOI: 10.1016/0006-8993(94)91613-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

3.  Increase of flexor reflex latency in patients with amyotrophic lateral sclerosis treated with riluzole.

Authors:  M W Riepe; G Klappenbach; A C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 4.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

Review 5.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

Review 6.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  P J Shaw; C J Eggett
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

Review 7.  Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Authors:  Sandra R Bacman; Walter G Bradley; Carlos T Moraes
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

8.  Regional distribution of sodium-dependent excitatory amino acid transporters in rat spinal cord.

Authors:  Susan A Queen; J Patrick Kesslak; Richard J Bridges
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.